Type(s) of Cancer
Lung
Lung
Study Phase
Phase 3
Study Completion Date
June 2013
June 2013
NCT00533949Uploaded 01-30-2018
Access via NCI by Request
PDS UID: nci-data-361
A Randomized Phase III Comparison of Standard-Dose (60 Gy) Versus High-Dose (74 Gy) Conformal Radiotherapy With Concurrent and Consolidation Carboplatin/Paclitaxel +/- Cetuximab (IND #103444) in Patients With Stage IIIA/IIIB Non-Small Cell Lung Cancer
Files: NCT00533949-D3
Data DictionaryNCT00533949-D3-Data-Dictionary.pdf
DATANCT00533949-D3-Dataset.csv
OTHERREADME.pdf
Files: NCT00533949-D2
Data DictionaryNCT00533949-D2-Data-Dictionary.pdf
DATANCT00533949-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT00533949-D1
Data DictionaryNCT00533949-D1-Data-Dictionary.pdf
DATANCT00533949-D1-Dataset.csv
OTHERREADME.pdf